nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—CYP1A2—type 2 diabetes mellitus	0.169	0.602	CbGaD
Rilpivirine—CYP3A4—type 2 diabetes mellitus	0.112	0.398	CbGaD
Rilpivirine—SLCO1B3—Pioglitazone—type 2 diabetes mellitus	0.0627	0.114	CbGbCtD
Rilpivirine—SLCO1B3—Valsartan—type 2 diabetes mellitus	0.0511	0.0931	CbGbCtD
Rilpivirine—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0403	0.0736	CbGbCtD
Rilpivirine—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0365	0.0665	CbGbCtD
Rilpivirine—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0337	0.0614	CbGbCtD
Rilpivirine—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0297	0.0542	CbGbCtD
Rilpivirine—SLCO1B3—Losartan—type 2 diabetes mellitus	0.0293	0.0535	CbGbCtD
Rilpivirine—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0171	0.0312	CbGbCtD
Rilpivirine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0162	0.0296	CbGbCtD
Rilpivirine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0152	0.0278	CbGbCtD
Rilpivirine—ABCG2—Glyburide—type 2 diabetes mellitus	0.0148	0.0271	CbGbCtD
Rilpivirine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0145	0.0264	CbGbCtD
Rilpivirine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.013	0.0236	CbGbCtD
Rilpivirine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.013	0.0236	CbGbCtD
Rilpivirine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.012	0.0218	CbGbCtD
Rilpivirine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0115	0.0211	CbGbCtD
Rilpivirine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.011	0.0201	CbGbCtD
Rilpivirine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0105	0.0191	CbGbCtD
Rilpivirine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00972	0.0177	CbGbCtD
Rilpivirine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00869	0.0158	CbGbCtD
Rilpivirine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00866	0.0158	CbGbCtD
Rilpivirine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00821	0.015	CbGbCtD
Rilpivirine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00792	0.0144	CbGbCtD
Rilpivirine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00718	0.0131	CbGbCtD
Rilpivirine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00692	0.0126	CbGbCtD
Rilpivirine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00663	0.0121	CbGbCtD
Rilpivirine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00626	0.0114	CbGbCtD
Rilpivirine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00607	0.0111	CbGbCtD
Rilpivirine—CYP1A2—Losartan—type 2 diabetes mellitus	0.0056	0.0102	CbGbCtD
Rilpivirine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00535	0.00976	CbGbCtD
Rilpivirine—ABCB1—Losartan—type 2 diabetes mellitus	0.00489	0.00892	CbGbCtD
Rilpivirine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00475	0.00865	CbGbCtD
Rilpivirine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00455	0.0083	CbGbCtD
Rilpivirine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00455	0.0083	CbGbCtD
Rilpivirine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0043	0.00785	CbGbCtD
Rilpivirine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00321	0.00585	CbGbCtD
Rilpivirine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00293	0.00535	CbGbCtD
Rilpivirine—Etravirine—CYP3A4—type 2 diabetes mellitus	0.000942	0.478	CrCbGaD
Rilpivirine—Pazopanib—CYP1A2—type 2 diabetes mellitus	0.000619	0.314	CrCbGaD
Rilpivirine—Pazopanib—CYP3A4—type 2 diabetes mellitus	0.00041	0.208	CrCbGaD
Rilpivirine—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.000237	0.00223	CcSEcCtD
Rilpivirine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000237	0.00223	CcSEcCtD
Rilpivirine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00222	CcSEcCtD
Rilpivirine—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000236	0.00222	CcSEcCtD
Rilpivirine—Blood creatinine increased—Ramipril—type 2 diabetes mellitus	0.000235	0.00221	CcSEcCtD
Rilpivirine—Infection—Bromocriptine—type 2 diabetes mellitus	0.000234	0.00221	CcSEcCtD
Rilpivirine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000233	0.00219	CcSEcCtD
Rilpivirine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000233	0.00219	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000232	0.00218	CcSEcCtD
Rilpivirine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000232	0.00218	CcSEcCtD
Rilpivirine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000232	0.00218	CcSEcCtD
Rilpivirine—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000232	0.00218	CcSEcCtD
Rilpivirine—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000231	0.00218	CcSEcCtD
Rilpivirine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00023	0.00216	CcSEcCtD
Rilpivirine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00216	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000229	0.00216	CcSEcCtD
Rilpivirine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000227	0.00214	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000227	0.00213	CcSEcCtD
Rilpivirine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00213	CcSEcCtD
Rilpivirine—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000226	0.00213	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000226	0.00213	CcSEcCtD
Rilpivirine—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000226	0.00212	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000225	0.00212	CcSEcCtD
Rilpivirine—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000225	0.00212	CcSEcCtD
Rilpivirine—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000224	0.0021	CcSEcCtD
Rilpivirine—Renal failure—Losartan—type 2 diabetes mellitus	0.000222	0.00209	CcSEcCtD
Rilpivirine—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000222	0.00209	CcSEcCtD
Rilpivirine—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000219	0.00207	CcSEcCtD
Rilpivirine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000219	0.00206	CcSEcCtD
Rilpivirine—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000218	0.00205	CcSEcCtD
Rilpivirine—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000217	0.00204	CcSEcCtD
Rilpivirine—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000215	0.00203	CcSEcCtD
Rilpivirine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000215	0.00203	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000214	0.00201	CcSEcCtD
Rilpivirine—Rash—Repaglinide—type 2 diabetes mellitus	0.000214	0.00201	CcSEcCtD
Rilpivirine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000213	0.00201	CcSEcCtD
Rilpivirine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000213	0.00201	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000213	0.00201	CcSEcCtD
Rilpivirine—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000213	0.002	CcSEcCtD
Rilpivirine—Headache—Repaglinide—type 2 diabetes mellitus	0.000212	0.002	CcSEcCtD
Rilpivirine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000212	0.00199	CcSEcCtD
Rilpivirine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000212	0.00199	CcSEcCtD
Rilpivirine—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000211	0.00199	CcSEcCtD
Rilpivirine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00021	0.00197	CcSEcCtD
Rilpivirine—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000208	0.00196	CcSEcCtD
Rilpivirine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000207	0.00195	CcSEcCtD
Rilpivirine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000206	0.00194	CcSEcCtD
Rilpivirine—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000206	0.00194	CcSEcCtD
Rilpivirine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00193	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000204	0.00192	CcSEcCtD
Rilpivirine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000203	0.00191	CcSEcCtD
Rilpivirine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000202	0.0019	CcSEcCtD
Rilpivirine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000202	0.0019	CcSEcCtD
Rilpivirine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000201	0.0019	CcSEcCtD
Rilpivirine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000201	0.00189	CcSEcCtD
Rilpivirine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000201	0.00189	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000201	0.00189	CcSEcCtD
Rilpivirine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000201	0.00189	CcSEcCtD
Rilpivirine—Malnutrition—Metformin—type 2 diabetes mellitus	0.000199	0.00187	CcSEcCtD
Rilpivirine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000198	0.00186	CcSEcCtD
Rilpivirine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000194	0.00183	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000193	0.00182	CcSEcCtD
Rilpivirine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000193	0.00181	CcSEcCtD
Rilpivirine—Infection—Gliclazide—type 2 diabetes mellitus	0.000192	0.00181	CcSEcCtD
Rilpivirine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000192	0.0018	CcSEcCtD
Rilpivirine—Renal failure—Ramipril—type 2 diabetes mellitus	0.00019	0.00179	CcSEcCtD
Rilpivirine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00019	0.00179	CcSEcCtD
Rilpivirine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00019	0.00179	CcSEcCtD
Rilpivirine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000188	0.00177	CcSEcCtD
Rilpivirine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000188	0.00177	CcSEcCtD
Rilpivirine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000188	0.00176	CcSEcCtD
Rilpivirine—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000187	0.00176	CcSEcCtD
Rilpivirine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000187	0.00176	CcSEcCtD
Rilpivirine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000187	0.00176	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000186	0.00175	CcSEcCtD
Rilpivirine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000185	0.00174	CcSEcCtD
Rilpivirine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000185	0.00174	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000184	0.00174	CcSEcCtD
Rilpivirine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000184	0.00173	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000183	0.00172	CcSEcCtD
Rilpivirine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000183	0.00172	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000182	0.00171	CcSEcCtD
Rilpivirine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000182	0.00171	CcSEcCtD
Rilpivirine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000179	0.00169	CcSEcCtD
Rilpivirine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000179	0.00168	CcSEcCtD
Rilpivirine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000178	0.00168	CcSEcCtD
Rilpivirine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000178	0.00168	CcSEcCtD
Rilpivirine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000178	0.00167	CcSEcCtD
Rilpivirine—Infection—Valsartan—type 2 diabetes mellitus	0.000177	0.00166	CcSEcCtD
Rilpivirine—Rash—Glipizide—type 2 diabetes mellitus	0.000177	0.00166	CcSEcCtD
Rilpivirine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000177	0.00166	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000176	0.00166	CcSEcCtD
Rilpivirine—Headache—Glipizide—type 2 diabetes mellitus	0.000176	0.00165	CcSEcCtD
Rilpivirine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000175	0.00165	CcSEcCtD
Rilpivirine—Infection—Orlistat—type 2 diabetes mellitus	0.000175	0.00164	CcSEcCtD
Rilpivirine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000175	0.00164	CcSEcCtD
Rilpivirine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000173	0.00163	CcSEcCtD
Rilpivirine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000173	0.00163	CcSEcCtD
Rilpivirine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000172	0.00162	CcSEcCtD
Rilpivirine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000172	0.00162	CcSEcCtD
Rilpivirine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000172	0.00162	CcSEcCtD
Rilpivirine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000171	0.00161	CcSEcCtD
Rilpivirine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000171	0.0016	CcSEcCtD
Rilpivirine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000169	0.00159	CcSEcCtD
Rilpivirine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000168	0.00158	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000168	0.00158	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000167	0.00157	CcSEcCtD
Rilpivirine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000167	0.00157	CcSEcCtD
Rilpivirine—Nausea—Glipizide—type 2 diabetes mellitus	0.000167	0.00157	CcSEcCtD
Rilpivirine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000166	0.00157	CcSEcCtD
Rilpivirine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000166	0.00156	CcSEcCtD
Rilpivirine—Rash—Glimepiride—type 2 diabetes mellitus	0.000165	0.00155	CcSEcCtD
Rilpivirine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000165	0.00155	CcSEcCtD
Rilpivirine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000164	0.00155	CcSEcCtD
Rilpivirine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000164	0.00155	CcSEcCtD
Rilpivirine—Headache—Glimepiride—type 2 diabetes mellitus	0.000164	0.00154	CcSEcCtD
Rilpivirine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000163	0.00154	CcSEcCtD
Rilpivirine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000161	0.00152	CcSEcCtD
Rilpivirine—Infection—Metformin—type 2 diabetes mellitus	0.000161	0.00152	CcSEcCtD
Rilpivirine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000161	0.00151	CcSEcCtD
Rilpivirine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000159	0.0015	CcSEcCtD
Rilpivirine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000159	0.0015	CcSEcCtD
Rilpivirine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000159	0.0015	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000158	0.00149	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000158	0.00149	CcSEcCtD
Rilpivirine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000158	0.00149	CcSEcCtD
Rilpivirine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000157	0.00148	CcSEcCtD
Rilpivirine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000157	0.00148	CcSEcCtD
Rilpivirine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00147	CcSEcCtD
Rilpivirine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000156	0.00147	CcSEcCtD
Rilpivirine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000155	0.00146	CcSEcCtD
Rilpivirine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000155	0.00146	CcSEcCtD
Rilpivirine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000155	0.00146	CcSEcCtD
Rilpivirine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000155	0.00146	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000154	0.00145	CcSEcCtD
Rilpivirine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000153	0.00144	CcSEcCtD
Rilpivirine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000153	0.00144	CcSEcCtD
Rilpivirine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000153	0.00144	CcSEcCtD
Rilpivirine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000152	0.00143	CcSEcCtD
Rilpivirine—Infection—Irbesartan—type 2 diabetes mellitus	0.000152	0.00143	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000152	0.00143	CcSEcCtD
Rilpivirine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000152	0.00143	CcSEcCtD
Rilpivirine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000151	0.00142	CcSEcCtD
Rilpivirine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00015	0.00141	CcSEcCtD
Rilpivirine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00015	0.00141	CcSEcCtD
Rilpivirine—Anxiety—Losartan—type 2 diabetes mellitus	0.00015	0.00141	CcSEcCtD
Rilpivirine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000149	0.0014	CcSEcCtD
Rilpivirine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000149	0.0014	CcSEcCtD
Rilpivirine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000149	0.0014	CcSEcCtD
Rilpivirine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000148	0.00139	CcSEcCtD
Rilpivirine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000148	0.00139	CcSEcCtD
Rilpivirine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000147	0.00138	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000146	0.00137	CcSEcCtD
Rilpivirine—Somnolence—Metformin—type 2 diabetes mellitus	0.000144	0.00136	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000144	0.00135	CcSEcCtD
Rilpivirine—Infection—Losartan—type 2 diabetes mellitus	0.000143	0.00135	CcSEcCtD
Rilpivirine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000141	0.00133	CcSEcCtD
Rilpivirine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000141	0.00133	CcSEcCtD
Rilpivirine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000141	0.00132	CcSEcCtD
Rilpivirine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00014	0.00132	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00014	0.00132	CcSEcCtD
Rilpivirine—Fatigue—Metformin—type 2 diabetes mellitus	0.00014	0.00131	CcSEcCtD
Rilpivirine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000139	0.00131	CcSEcCtD
Rilpivirine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000139	0.00131	CcSEcCtD
Rilpivirine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000137	0.00129	CcSEcCtD
Rilpivirine—Rash—Glyburide—type 2 diabetes mellitus	0.000136	0.00128	CcSEcCtD
Rilpivirine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000136	0.00128	CcSEcCtD
Rilpivirine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000136	0.00128	CcSEcCtD
Rilpivirine—Headache—Glyburide—type 2 diabetes mellitus	0.000135	0.00127	CcSEcCtD
Rilpivirine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000133	0.00125	CcSEcCtD
Rilpivirine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000133	0.00125	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000133	0.00125	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000132	0.00124	CcSEcCtD
Rilpivirine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000132	0.00124	CcSEcCtD
Rilpivirine—Insomnia—Losartan—type 2 diabetes mellitus	0.00013	0.00123	CcSEcCtD
Rilpivirine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000128	0.00121	CcSEcCtD
Rilpivirine—Nausea—Glyburide—type 2 diabetes mellitus	0.000128	0.00121	CcSEcCtD
Rilpivirine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000128	0.00121	CcSEcCtD
Rilpivirine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000128	0.00121	CcSEcCtD
Rilpivirine—Somnolence—Losartan—type 2 diabetes mellitus	0.000128	0.0012	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000128	0.0012	CcSEcCtD
Rilpivirine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000128	0.0012	CcSEcCtD
Rilpivirine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000126	0.00119	CcSEcCtD
Rilpivirine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000126	0.00118	CcSEcCtD
Rilpivirine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000125	0.00118	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000125	0.00118	CcSEcCtD
Rilpivirine—Fatigue—Losartan—type 2 diabetes mellitus	0.000124	0.00117	CcSEcCtD
Rilpivirine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000123	0.00116	CcSEcCtD
Rilpivirine—Rash—Gliclazide—type 2 diabetes mellitus	0.000122	0.00115	CcSEcCtD
Rilpivirine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000122	0.00115	CcSEcCtD
Rilpivirine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000122	0.00115	CcSEcCtD
Rilpivirine—Headache—Gliclazide—type 2 diabetes mellitus	0.000121	0.00114	CcSEcCtD
Rilpivirine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000121	0.00114	CcSEcCtD
Rilpivirine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000121	0.00114	CcSEcCtD
Rilpivirine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00012	0.00113	CcSEcCtD
Rilpivirine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.00113	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000118	0.00111	CcSEcCtD
Rilpivirine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000118	0.00111	CcSEcCtD
Rilpivirine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000116	0.00109	CcSEcCtD
Rilpivirine—Asthenia—Metformin—type 2 diabetes mellitus	0.000116	0.00109	CcSEcCtD
Rilpivirine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000115	0.00108	CcSEcCtD
Rilpivirine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000114	0.00107	CcSEcCtD
Rilpivirine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000113	0.00106	CcSEcCtD
Rilpivirine—Rash—Valsartan—type 2 diabetes mellitus	0.000112	0.00106	CcSEcCtD
Rilpivirine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000112	0.00106	CcSEcCtD
Rilpivirine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000112	0.00105	CcSEcCtD
Rilpivirine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000112	0.00105	CcSEcCtD
Rilpivirine—Headache—Valsartan—type 2 diabetes mellitus	0.000111	0.00105	CcSEcCtD
Rilpivirine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000111	0.00104	CcSEcCtD
Rilpivirine—Rash—Orlistat—type 2 diabetes mellitus	0.000111	0.00104	CcSEcCtD
Rilpivirine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000111	0.00104	CcSEcCtD
Rilpivirine—Headache—Orlistat—type 2 diabetes mellitus	0.00011	0.00104	CcSEcCtD
Rilpivirine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00011	0.00103	CcSEcCtD
Rilpivirine—Somnolence—Ramipril—type 2 diabetes mellitus	0.00011	0.00103	CcSEcCtD
Rilpivirine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000107	0.00101	CcSEcCtD
Rilpivirine—Dizziness—Metformin—type 2 diabetes mellitus	0.000107	0.00101	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000107	0.001	CcSEcCtD
Rilpivirine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000106	0.001	CcSEcCtD
Rilpivirine—Nausea—Valsartan—type 2 diabetes mellitus	0.000106	0.000995	CcSEcCtD
Rilpivirine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000105	0.000985	CcSEcCtD
Rilpivirine—Nausea—Orlistat—type 2 diabetes mellitus	0.000104	0.000983	CcSEcCtD
Rilpivirine—Asthenia—Losartan—type 2 diabetes mellitus	0.000103	0.000972	CcSEcCtD
Rilpivirine—Vomiting—Metformin—type 2 diabetes mellitus	0.000103	0.00097	CcSEcCtD
Rilpivirine—Rash—Metformin—type 2 diabetes mellitus	0.000102	0.000962	CcSEcCtD
Rilpivirine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000102	0.000961	CcSEcCtD
Rilpivirine—Headache—Metformin—type 2 diabetes mellitus	0.000102	0.000955	CcSEcCtD
Rilpivirine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000101	0.000952	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000101	0.00095	CcSEcCtD
Rilpivirine—Diarrhoea—Losartan—type 2 diabetes mellitus	9.85e-05	0.000927	CcSEcCtD
Rilpivirine—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.76e-05	0.000918	CcSEcCtD
Rilpivirine—Vomiting—Irbesartan—type 2 diabetes mellitus	9.72e-05	0.000915	CcSEcCtD
Rilpivirine—Rash—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000908	CcSEcCtD
Rilpivirine—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000907	CcSEcCtD
Rilpivirine—Nausea—Metformin—type 2 diabetes mellitus	9.63e-05	0.000906	CcSEcCtD
Rilpivirine—Headache—Irbesartan—type 2 diabetes mellitus	9.58e-05	0.000902	CcSEcCtD
Rilpivirine—Dizziness—Losartan—type 2 diabetes mellitus	9.52e-05	0.000896	CcSEcCtD
Rilpivirine—Vomiting—Losartan—type 2 diabetes mellitus	9.15e-05	0.000861	CcSEcCtD
Rilpivirine—Nausea—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000855	CcSEcCtD
Rilpivirine—Rash—Losartan—type 2 diabetes mellitus	9.08e-05	0.000854	CcSEcCtD
Rilpivirine—Dermatitis—Losartan—type 2 diabetes mellitus	9.07e-05	0.000853	CcSEcCtD
Rilpivirine—Headache—Losartan—type 2 diabetes mellitus	9.02e-05	0.000849	CcSEcCtD
Rilpivirine—Asthenia—Ramipril—type 2 diabetes mellitus	8.86e-05	0.000833	CcSEcCtD
Rilpivirine—Nausea—Losartan—type 2 diabetes mellitus	8.55e-05	0.000805	CcSEcCtD
Rilpivirine—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000795	CcSEcCtD
Rilpivirine—Dizziness—Ramipril—type 2 diabetes mellitus	8.16e-05	0.000768	CcSEcCtD
Rilpivirine—Vomiting—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000738	CcSEcCtD
Rilpivirine—Rash—Ramipril—type 2 diabetes mellitus	7.78e-05	0.000732	CcSEcCtD
Rilpivirine—Dermatitis—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000732	CcSEcCtD
Rilpivirine—Headache—Ramipril—type 2 diabetes mellitus	7.73e-05	0.000728	CcSEcCtD
Rilpivirine—Nausea—Ramipril—type 2 diabetes mellitus	7.33e-05	0.00069	CcSEcCtD
Rilpivirine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	5.94e-06	9.47e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	5.93e-06	9.45e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	5.93e-06	9.45e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	5.93e-06	9.45e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	5.93e-06	9.45e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	5.9e-06	9.41e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	5.9e-06	9.41e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	5.9e-06	9.41e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	5.9e-06	9.41e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	5.88e-06	9.38e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.87e-06	9.35e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	5.83e-06	9.3e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.79e-06	9.23e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.79e-06	9.23e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.76e-06	9.18e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.7e-06	9.09e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	5.7e-06	9.08e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.69e-06	9.08e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	5.69e-06	9.06e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	5.6e-06	8.93e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.59e-06	8.91e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	5.58e-06	8.9e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.57e-06	8.88e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.57e-06	8.88e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.52e-06	8.8e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	5.52e-06	8.8e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.48e-06	8.73e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.44e-06	8.67e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	5.42e-06	8.64e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	5.42e-06	8.64e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	5.42e-06	8.64e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.41e-06	8.62e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.38e-06	8.58e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.38e-06	8.58e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.38e-06	8.58e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	5.36e-06	8.55e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.36e-06	8.55e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.35e-06	8.53e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	5.34e-06	8.51e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	5.32e-06	8.48e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.29e-06	8.44e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.29e-06	8.44e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.29e-06	8.44e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.29e-06	8.42e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	5.28e-06	8.41e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	5.27e-06	8.4e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	5.25e-06	8.37e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.2e-06	8.29e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5.2e-06	8.28e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	5.16e-06	8.23e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	5.15e-06	8.21e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	5.15e-06	8.21e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	5.11e-06	8.15e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.06e-06	8.07e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.05e-06	8.05e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.04e-06	8.03e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	4.98e-06	7.93e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.96e-06	7.91e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.94e-06	7.87e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.91e-06	7.82e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.91e-06	7.82e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	4.88e-06	7.78e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	4.86e-06	7.75e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.84e-06	7.72e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.84e-06	7.71e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.84e-06	7.71e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.79e-06	7.63e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.79e-06	7.63e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.78e-06	7.62e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	4.78e-06	7.62e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—INS—type 2 diabetes mellitus	4.77e-06	7.6e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	4.76e-06	7.59e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.76e-06	7.58e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.74e-06	7.56e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.74e-06	7.55e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	4.72e-06	7.53e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.71e-06	7.51e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.71e-06	7.51e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.71e-06	7.51e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.71e-06	7.51e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.7e-06	7.49e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.7e-06	7.49e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.68e-06	7.46e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.67e-06	7.44e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	4.64e-06	7.39e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.6e-06	7.33e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.59e-06	7.32e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.59e-06	7.32e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.58e-06	7.3e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.58e-06	7.3e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.58e-06	7.3e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.58e-06	7.3e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.58e-06	7.3e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.55e-06	7.24e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	4.52e-06	7.2e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.52e-06	7.2e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	4.4e-06	7.01e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.39e-06	6.99e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	4.37e-06	6.97e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	4.31e-06	6.87e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.24e-06	6.76e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.23e-06	6.74e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.23e-06	6.74e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.23e-06	6.74e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.18e-06	6.67e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	4.18e-06	6.67e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	4.18e-06	6.66e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.15e-06	6.61e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	4.13e-06	6.59e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.11e-06	6.55e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.11e-06	6.55e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.09e-06	6.52e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.08e-06	6.5e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.05e-06	6.46e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.05e-06	6.46e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.05e-06	6.46e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.05e-06	6.45e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.03e-06	6.43e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.02e-06	6.41e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.98e-06	6.34e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.96e-06	6.3e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.96e-06	6.3e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.94e-06	6.28e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.89e-06	6.19e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.87e-06	6.16e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.86e-06	6.16e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	3.83e-06	6.1e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.82e-06	6.09e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.81e-06	6.07e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.77e-06	6.01e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.76e-06	5.99e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.73e-06	5.95e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.73e-06	5.95e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.73e-06	5.94e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.71e-06	5.91e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.69e-06	5.88e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.67e-06	5.85e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.66e-06	5.84e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.66e-06	5.84e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.66e-06	5.83e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.64e-06	5.8e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.64e-06	5.8e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.64e-06	5.8e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.61e-06	5.76e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.61e-06	5.76e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.6e-06	5.74e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.6e-06	5.74e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.57e-06	5.68e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.55e-06	5.66e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.53e-06	5.62e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.51e-06	5.6e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.51e-06	5.59e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.51e-06	5.59e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.5e-06	5.57e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.46e-06	5.52e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.42e-06	5.45e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.38e-06	5.39e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.32e-06	5.3e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.26e-06	5.2e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.26e-06	5.2e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.26e-06	5.2e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.26e-06	5.19e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.24e-06	5.17e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.21e-06	5.11e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.2e-06	5.1e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.18e-06	5.07e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.17e-06	5.06e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.16e-06	5.03e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.16e-06	5.03e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.16e-06	5.03e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.14e-06	5.01e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.1e-06	4.95e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.1e-06	4.95e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.1e-06	4.94e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.09e-06	4.93e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKT1—type 2 diabetes mellitus	3.09e-06	4.93e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.08e-06	4.91e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.07e-06	4.89e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.07e-06	4.89e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.06e-06	4.87e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.03e-06	4.83e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.02e-06	4.81e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.01e-06	4.8e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.98e-06	4.76e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.98e-06	4.75e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.95e-06	4.7e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.95e-06	4.7e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.93e-06	4.67e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.88e-06	4.58e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.83e-06	4.51e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.83e-06	4.51e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.81e-06	4.49e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.81e-06	4.47e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.8e-06	4.47e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.73e-06	4.35e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.7e-06	4.3e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.69e-06	4.29e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.64e-06	4.21e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.63e-06	4.19e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.59e-06	4.13e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.58e-06	4.11e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.54e-06	4.05e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.46e-06	3.92e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.44e-06	3.88e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.44e-06	3.88e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.43e-06	3.87e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.42e-06	3.86e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.42e-06	3.85e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.41e-06	3.84e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.39e-06	3.82e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.38e-06	3.8e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.36e-06	3.77e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.32e-06	3.7e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.32e-06	3.69e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.32e-06	3.69e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.26e-06	3.6e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.26e-06	3.6e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.26e-06	3.6e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.22e-06	3.54e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.17e-06	3.46e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.17e-06	3.45e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.12e-06	3.38e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.11e-06	3.36e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.1e-06	3.35e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.08e-06	3.32e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	2.08e-06	3.31e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.07e-06	3.3e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.06e-06	3.28e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2e-06	3.18e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.96e-06	3.12e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.92e-06	3.06e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.9e-06	3.03e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.89e-06	3.01e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.87e-06	2.97e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.86e-06	2.96e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.84e-06	2.93e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.81e-06	2.88e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.81e-06	2.88e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	2.63e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.62e-06	2.58e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.59e-06	2.53e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.46e-06	2.32e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.41e-06	2.25e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.39e-06	2.22e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.39e-06	2.22e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.27e-06	2.03e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.07e-06	1.7e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.04e-06	1.66e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.3e-07	1.32e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.41e-07	1.02e-05	CbGpPWpGaD
